Audit 382757

FY End
2025-09-30
Total Expended
$1.31M
Findings
0
Programs
5
Year: 2025 Accepted: 2026-01-20

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.837 CARDIOVASCULAR DISEASES RESEARCH $607,525 Yes 0
93.273 ALCOHOL RESEARCH PROGRAMS $285,435 Yes 0
12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT $67,234 Yes 0
93.RD Patient Centered Outcomes Research Trust Fund $14,477 Yes 0
93.866 AGING RESEARCH $6,305 Yes 0

Contacts

Name Title Type
F23LDFFMGTZ6 Bethanne Wenzel Auditee
7188366600 Bennie Lewis Auditor
No contacts on file

Notes to SEFA

The Organization receives federal financial assistance from various organizations which are pass-through awards from federal grantors. The amounts of direct awards and pass-through awards are included on the schedule of expenditures of federal awards.
Of the federal expenditures presented in the Schedule, the Organization provided federal awards to subrecipients as follows: CFDA Number: 12.420 Federal Program: U.S Army Medical research Acquisition Activity Amount Provided to Subrecipients: $55,723 CFDA Number: 93.837 Federal Program: National Heart, Lung and Blood Institute Amount Provided to Subrecipient: $340,059 Total Amount Provided to Subrecipients: $395,782 The Organization has certain compliance responsibilities, such as monitoring its subrecipients to help assure they use these sub-awards as authorized by laws, regulations, and the provisions of contracts or grant agreements, and that subrecipients achieve the award’s performance goals.